Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack

Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack

Background Metabolic syndrome (MetS) attenuates antiplatelet agent effects. This study investigated the efficacy and safety of clopidogrel–aspirin therapy for secondary stroke prevention in patients with MetS. Methods Data were obtained from the INSPIRES (Intensive Statin and Antiplatelet Therapy fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Xia, Ying Gao, Weiqi Chen, S. Claiborne Johnston, Pierre Amarenco, Philip M. Bath, Xuan Wang, Hongyi Yan, Tingting Wang, Yingying Yang, Yanli Zhang, Mengxing Wang, Jing Jing, Chunjuan Wang, Yongjun Wang, Yilong Wang, Yuesong Pan
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
dual antiplatelet therapy
ischemic stroke
metabolic syndrome
secondary prevention
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.125.041449
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items